US 12,329,932 B2
Methods for providing an alert or an alarm to a user of a mobile communications device
Gary A. Morris, San Marcos, CA (US); Scott M. Belliveau, San Diego, CA (US); Esteban Cabrera, Jr., San Diego, CA (US); Anna Leigh Davis, San Diego, CA (US); Rian W. Draeger, San Diego, CA (US); Laura J. Dunn, San Diego, CA (US); Timothy Joseph Goldsmith, San Diego, CA (US); Hari Hampapuram, Beaverton, OR (US); Christopher Robert Hannemann, San Diego, CA (US); Apurv Ullas Kamath, San Diego, CA (US); Katherine Yerre Koehler, Solana Beach, CA (US); Patrick Wile McBride, San Diego, CA (US); Michael Robert Mensinger, San Diego, CA (US); Francis William Pascual, San Diego, CA (US); Philip Mansiel Pellouchoud, San Diego, CA (US); Nicholas Polytaridis, San Diego, CA (US); Philip Thomas Pupa, San Diego, CA (US); Kevin Shoemaker, San Diego, CA (US); Brian Christopher Smith, San Diego, CA (US); Benjamin Elrod West, San Diego, CA (US); and Atiim Joseph Wiley, San Diego, CA (US)
Assigned to Dexcom, Inc., San Diego, CA (US)
Filed by Dexcom, Inc., San Diego, CA (US)
Filed on Jul. 15, 2024, as Appl. No. 18/773,421.
Application 18/773,421 is a continuation of application No. 18/465,839, filed on Sep. 12, 2023, granted, now 12,064,601.
Application 18/465,839 is a continuation of application No. 18/065,943, filed on Dec. 14, 2022, granted, now 11,826,549, issued on Nov. 28, 2023.
Application 18/065,943 is a continuation of application No. 17/202,845, filed on Mar. 16, 2021, granted, now 11,969,578, issued on Apr. 30, 2024.
Application 15/475,010 is a continuation of application No. 15/474,886, filed on Mar. 30, 2017, granted, now 10,596,318, issued on Mar. 24, 2020.
Application 17/202,845 is a continuation of application No. 15/475,010, filed on Mar. 30, 2017, granted, now 10,980,941, issued on Apr. 20, 2024.
Claims priority of provisional application 62/370,182, filed on Aug. 2, 2016.
Claims priority of provisional application 62/315,948, filed on Mar. 31, 2016.
Prior Publication US 2024/0366872 A1, Nov. 7, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/172 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); G06F 9/54 (2006.01); G06F 16/22 (2019.01); G06F 16/955 (2019.01); G06F 21/60 (2013.01); G08B 21/04 (2006.01); G08B 25/08 (2006.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); H04L 9/06 (2006.01); H04L 9/08 (2006.01); H04L 9/14 (2006.01); H04L 9/30 (2006.01); H04L 9/40 (2022.01); H04M 1/72409 (2021.01); H04M 1/72412 (2021.01); H04W 12/084 (2021.01)
CPC A61M 5/1723 (2013.01) [A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61B 5/7405 (2013.01); A61B 5/742 (2013.01); G06F 9/54 (2013.01); G06F 9/546 (2013.01); G06F 16/2228 (2019.01); G06F 16/955 (2019.01); G06F 21/606 (2013.01); G08B 21/0453 (2013.01); G08B 25/08 (2013.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); H04L 9/0637 (2013.01); H04L 9/0822 (2013.01); H04L 9/0833 (2013.01); H04L 9/0861 (2013.01); H04L 9/0891 (2013.01); H04L 9/14 (2013.01); H04L 9/30 (2013.01); H04L 63/0428 (2013.01); H04M 1/72409 (2021.01); H04W 12/084 (2021.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2230/201 (2013.01); H04L 2209/80 (2013.01); H04M 1/724095 (2022.02); H04M 1/72412 (2021.01)] 20 Claims
OG exemplary drawing
 
1. A mobile communications device, comprising:
a memory comprising a first software module and a second software module;
a processor in data communication with the memory and configured to:
receive, via the second software module, glucose measurements from a glucose monitoring system;
determine, via the first software module, an insulin dosage based on the received glucose measurements, wherein:
the first and second software modules are different software modules;
the first software module is operable to receive patient specific input data and calculate the insulin dosage based on the patient specific input data and the received glucose measurements; and
the second software module is a plug-in for a software application comprising the first software module; and
transmit a command indicative of the determined insulin dosage to an insulin delivery device to cause the insulin delivery device to administer the insulin dosage to a patient.